Cara Therapeutics Inc (CARA)
0.296
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.296
0.00 (0.00%)
After-Hours: 16:16
Cara Therapeutics Research and Development Expense (TTM): 85.14M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 85.14M |
| March 31, 2024 | 106.14M |
| December 31, 2023 | 108.51M |
| September 30, 2023 | 106.10M |
| June 30, 2023 | 105.34M |
| March 31, 2023 | 94.94M |
| December 31, 2022 | 91.88M |
| September 30, 2022 | 88.70M |
| June 30, 2022 | 79.52M |
| March 31, 2022 | 84.84M |
| December 31, 2021 | 82.70M |
| September 30, 2021 | 87.01M |
| June 30, 2021 | 92.56M |
| March 31, 2021 | 93.45M |
| December 31, 2020 | 107.85M |
| September 30, 2020 | 110.58M |
| June 30, 2020 | 125.50M |
| March 31, 2020 | 123.75M |
| December 31, 2019 | 113.82M |
| September 30, 2019 | 106.76M |
| June 30, 2019 | 93.07M |
| March 31, 2019 | 85.71M |
| Date | Value |
|---|---|
| December 31, 2018 | 75.53M |
| September 30, 2018 | 64.31M |
| June 30, 2018 | 51.16M |
| March 31, 2018 | 41.12M |
| December 31, 2017 | 48.52M |
| September 30, 2017 | 57.22M |
| June 30, 2017 | 57.74M |
| March 31, 2017 | 61.54M |
| December 31, 2016 | 49.25M |
| September 30, 2016 | 36.54M |
| June 30, 2016 | 32.46M |
| March 31, 2016 | 26.38M |
| December 31, 2015 | 21.22M |
| September 30, 2015 | 17.11M |
| June 30, 2015 | 17.74M |
| March 31, 2015 | 16.25M |
| December 31, 2014 | 15.07M |
| September 30, 2014 | 13.59M |
| June 30, 2014 | 11.14M |
| March 31, 2014 | 9.964M |
| December 31, 2013 | 8.685M |
| September 30, 2013 | 7.73M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
79.52M
Minimum
Jun 2022
125.50M
Maximum
Jun 2020
99.39M
Average
94.94M
Median
Mar 2023
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 28.53M |
| Alaunos Therapeutics Inc | 4.895M |
| Oragenics Inc | 13.38M |
| Cocrystal Pharma Inc | 15.72M |
| Citius Pharmaceuticals Inc | 11.87M |